Authors:
Menard, S
Camerini, T
Mariani, L
Tomasic, G
Pilotti, S
Costa, A
De Palo, G
Veronesi, U
Citation: S. Menard et al., Re: Randomized trial of fenretinide to prevent second breast malignancy inwomen with early breast cancer, J NAT CANC, 93(3), 2001, pp. 240-241
Authors:
Andreola, S
Leo, E
Belli, F
Bonfanti, G
Sirizzotti, G
Greco, P
Valvo, F
Tomasic, G
Gallino, GF
Citation: S. Andreola et al., Adenocarcinoma of the lower third of the rectum surgically treated with a < 10-MM distal clearance: Preliminary results in 35 N0 patients, ANN SURG O, 8(7), 2001, pp. 611-615
Authors:
Menard, S
Valagussa, P
Pilotti, S
Gianni, L
Biganzoli, E
Boracchi, P
Tomasic, G
Casalini, P
Marubini, E
Colnaghi, MI
Cascinelli, N
Bonadonna, G
Citation: S. Menard et al., Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables, J CL ONCOL, 19(2), 2001, pp. 329-335
Authors:
Coradini, D
Boracchi, P
Daidone, MG
Pellizzaro, C
Miodini, P
Ammatuna, M
Tomasic, G
Biganzoli, E
Citation: D. Coradini et al., Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer, BR J CANC, 85(6), 2001, pp. 795-797
Authors:
Sampietro, G
Tomasic, G
Collini, P
Biganzoli, E
Boracchi, P
Bidoli, P
Pilotti, S
Citation: G. Sampietro et al., Gene product immunophenotyping of neuroendocrine lung tumors - No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis, APPL IMMUNO, 8(1), 2000, pp. 49-56
Authors:
Daidone, MG
Luisi, A
Martelli, G
Benini, E
Veneroni, S
Tomasic, G
De Palo, G
Silvestrini, R
Citation: Mg. Daidone et al., Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women, BR J CANC, 82(2), 2000, pp. 270-277
Authors:
Greco, M
Agresti, R
Cascinelli, N
Casalini, P
Giovanazzi, R
Maucione, A
Tomasic, G
Ferraris, C
Ammatuna, M
Pilotti, S
Menard, S
Citation: M. Greco et al., Breast cancer patients treated without axillary surgery - Clinical implications and biologic analysis, ANN SURG, 232(1), 2000, pp. 1-7
Authors:
Damiani, S
Ludvikova, M
Tomasic, G
Bianchi, S
Gown, AM
Eusebi, V
Citation: S. Damiani et al., Myoepithelial cells and basal lamina in poorly differentiated in situ ductcarcinoma of the breast - An immunocytochemical study, VIRCHOWS AR, 434(3), 1999, pp. 227-234
Authors:
Menard, S
Casalini, P
Tomasic, G
Pilotti, S
Cascinelli, N
Bufalino, R
Perrone, F
Longhi, C
Rilke, F
Colnaghi, MI
Citation: S. Menard et al., Pathobiologic identification of two distinct breast carcinoma subsets withdiverging clinical behaviors, BREAST CANC, 55(2), 1999, pp. 169-177
Authors:
Daidone, MG
Veneroni, S
Benini, E
Tomasic, G
Coradini, D
Mastore, M
Brambilla, C
Ferrari, L
Silvestrini, R
Citation: Mg. Daidone et al., Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer, INT J CANC, 84(6), 1999, pp. 580-586